Actively Recruiting
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Led by Novartis Pharmaceuticals · Updated on 2025-04-24
700
Participants Needed
54
Research Sites
518 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
The purpose of this post-marketing study is to further characterize the long-term outcome of known or potential risks of lutetium (177Lu) vipivotide tetraxetan also known as \[177Lu\]Lu-PSMA-617 or 177Lu-PSMA-617 and hereinafter referred to as AAA617. The study also seeks to further characterize (as possible) any other AAA617 causally related serious adverse event(s) in the long-term in adults with prostate cancer who received at least one dose of AAA617 from interventional, Phase I-IV Novartis sponsored clinical trials.
CONDITIONS
Official Title
Long-Term Safety of Lutetium (177Lu) Vipivotide Tetraxetan in Participants With Prostate Cancer
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Signed informed consent must be obtained prior to participation in the study
- Must have received at least one dose of AAA617 within an interventional, Phase I-IV Novartis sponsored clinical trial in prostate cancer and have fulfilled the trial's requirements that allows them to participate in this study.
You will not qualify if you...
- Inability to complete the needed investigational examinations due to any reason.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 54 locations
1
Mayo Clinic Arizona
Scottsdale, Arizona, United States, 85259
Actively Recruiting
2
St. Joseph Hospital
Orange, California, United States, 92686
Actively Recruiting
3
Providence Saint Johns Health Ctr
Santa Monica, California, United States, 90404
Actively Recruiting
4
University of Colorado
Aurora, Colorado, United States, 80045
Actively Recruiting
5
Hartford Hospital
Hartford, Connecticut, United States, 06102
Actively Recruiting
6
VA Medical Center
Washington D.C., District of Columbia, United States, 20422
Actively Recruiting
7
Mayo Clinic Jacksonville
Jacksonville, Florida, United States, 32224
Actively Recruiting
8
University Cancer and Blood Center LLC
Athens, Georgia, United States, 30607
Actively Recruiting
9
Parkview Research Center
Fort Wayne, Indiana, United States, 46845
Actively Recruiting
10
Tulane Cancer Center
New Orleans, Louisiana, United States, 70112
Actively Recruiting
11
Ochsner Clinic Foundation
New Orleans, Louisiana, United States, 70121
Actively Recruiting
12
Corewell Health William Beaum Hosp
Royal Oak, Michigan, United States, 48073-6769
Actively Recruiting
13
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
14
University of Mississippi Med Ctr
Jackson, Mississippi, United States, 39216
Actively Recruiting
15
Wash U School of Medicine
St Louis, Missouri, United States, 63110
Actively Recruiting
16
Urology Cancer Center PC
Omaha, Nebraska, United States, 68130
Actively Recruiting
17
Nebraska Cancer Specialists
Omaha, Nebraska, United States, 68154
Actively Recruiting
18
Montefiore Medical Center
The Bronx, New York, United States, 10467
Actively Recruiting
19
Duke University Medical Center
Durham, North Carolina, United States, 27710
Actively Recruiting
20
Cleveland Clinic Foundation
Cleveland, Ohio, United States, 44195
Actively Recruiting
21
Univ of Pittsburgh Medical Center
Pittsburgh, Pennsylvania, United States, 15232
Actively Recruiting
22
Univ of Texas Southwest Med Center
Dallas, Texas, United States, 75390-9034
Actively Recruiting
23
UT Health Science Center
Houston, Texas, United States, 77030
Actively Recruiting
24
Onco Hemato Asso of SE Virginia
Roanoke, Virginia, United States, 24014
Actively Recruiting
25
Novartis Investigative Site
Linz, Austria, 4020
Actively Recruiting
26
Novartis Investigative Site
Vienna, Austria, 1090
Actively Recruiting
27
Novartis Investigative Site
Ghent, Belgium, 9000
Actively Recruiting
28
Novartis Investigative Site
Montreal, Quebec, Canada, H2X 1R9
Actively Recruiting
29
Novartis Investigative Site
Olomouc, Czechia, 779 00
Actively Recruiting
30
Novartis Investigative Site
Prague, Czechia, 150 06
Actively Recruiting
31
Novartis Investigative Site
Lyon, France, 69373
Actively Recruiting
32
Novartis Investigative Site
Essen, Germany, 45147
Actively Recruiting
33
Novartis Investigative Site
München, Germany, 80377
Actively Recruiting
34
Novartis Investigative Site
Rostock, Germany, 18057
Actively Recruiting
35
Novartis Investigative Site
Delft, Netherlands, 2625 AD
Actively Recruiting
36
Novartis Investigative Site
Maastricht, Netherlands, 6229 HX
Actively Recruiting
37
Novartis Investigative Site
Nijmegen, Netherlands, 6500HB
Actively Recruiting
38
Novartis Investigative Site
Sabadell, Barcelona, Spain, 08208
Actively Recruiting
39
Novartis Investigative Site
Barcelona, Catalonia, Spain, 08035
Actively Recruiting
40
Novartis Investigative Site
Barcelona, Catalonia, Spain, 08036
Actively Recruiting
41
Novartis Investigative Site
L'Hospitalet de Llobregat, Catalonia, Spain, 08907
Actively Recruiting
42
Novartis Investigative Site
Madrid, Spain, 28034
Actively Recruiting
43
Novartis Investigative Site
Madrid, Spain, 28040
Actively Recruiting
44
Novartis Investigative Site
Madrid, Spain, 28041
Actively Recruiting
45
Novartis Investigative Site
Madrid, Spain, 28046
Actively Recruiting
46
Novartis Investigative Site
Madrid, Spain, 28222
Actively Recruiting
47
Novartis Investigative Site
Valencia, Spain, 46026
Actively Recruiting
48
Novartis Investigative Site
Gothenburg, Sweden, 413 45
Actively Recruiting
49
Novartis Investigative Site
Stockholm, Sweden, 17176
Actively Recruiting
50
Novartis Investigative Site
Sutton, Surrey, United Kingdom, SM2 5PT
Actively Recruiting
51
Novartis Investigative Site
Barnet, United Kingdom, EN5 3DJ
Actively Recruiting
52
Novartis Investigative Site
Cambridge, United Kingdom, CB2 0QQ
Actively Recruiting
53
Novartis Investigative Site
Glasgow, United Kingdom, G12 0YN
Actively Recruiting
54
Novartis Investigative Site
Middlesbrough, United Kingdom, TS4 3BW
Actively Recruiting
Research Team
N
Novartis Pharmaceuticals
CONTACT
N
Novartis Pharmaceuticals
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
OTHER
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here